Publications by authors named "Lynette Chee"

Claim this Profile
I
Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations.
Naranie Shanmuganathan, David T Yeung, Carol Wadham, Adelina Fernandes, Muneeza Maqsood, Lynette Chee

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Clinical Outcomes of Multiple Viral Infections After Allogeneic Hematopoietic Cell Transplantation.
Kar Yee Yong, Shio Yen Tio, Beatrice Z Sim, Joe Sasadeusz, Alex Rivalland, Lynette Chee

Open Forum Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Changing Epidemiology of Breakthrough Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the Era of Modified-Release Posaconazole Prophylaxis.
Shio Yen Tio, Chin Fen Neoh, David Ritchie, Lynette Chee, David C M Kong

Transpl Infect Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asciminib remained superior vs bosutinib in late-line CML-CP after nearly 4 years of follow-up in ASCEMBL.
Michael J Mauro, Yosuke Minami, Andreas Hochhaus, Elza Lomaia, Sergey Voloshin, Lynette Chee

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clostridioides difficile infection and recurrence in cancer patients (CIRCA): A multicentre, international study.
Pedro Puerta-Alcalde, Jessica O'Keefe, Rachel Woolstencroft, Shipraa Kaul, Néstor López, Lynette Chee

Int J Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosis.
Rithin Nedumannil, Tal Karmi, Piers Blombery, Jeff Szer, David S Ritchie, Lynette C Y Chee

Br J Haematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The economic cost of care in poor graft function following allogeneic stem cell transplantation.
Manu Juneja, Ashvind Prabahran, Mayani Rawicki, Lynette C Y Chee, Rachel M Koldej

Bone Marrow Transplant· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.
Michelle A Neller, George R Ambalathingal, Nada Hamad, Joe Sasadeusz, Rebecca Pearson, Lynette Chee

Nat Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study.
David T Yeung, Naranie Shanmuganathan, John Reynolds, Susan Branford, Mannu Walia, Lynette Chee

Blood· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of chronic myeloid leukaemia patients taking asciminib through a Managed Access Programme (MAP) in Australia.
Lynette Chee, Nora Lee, Andrew Grigg, Melissa Chen, Anthony Schwarer

Intern Med J· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-free remission in CML patients with additional chromosome abnormalities in the Philadelphia-positive clone or variant Philadelphia translocations.
Simone Claudiani, Lynette Chee, Fiona Fernando, Loretta Brown, Udayakumar M Achandira

Am J Hematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ANZTCT consensus position statement on ruxolitinib in steroid-refractory acute and chronic graft-versus-host disease.
Nada Hamad, Ian Bilmon, Lynette Chee, Andrea Henden, Anna Johnston

Intern Med J· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells.
Thi H O Nguyen, Louise C Rowntree, Lilith F Allen, Brendon Y Chua, Lukasz Kedzierski, Lynette Chee

Cell Rep Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL.
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Lynette Chee

Leukemia· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective CMV prophylaxis with high-dose valaciclovir in allogeneic hematopoietic stem-cell recipients at a high risk of CMV infection.
Genevieve Douglas, Michelle K Yong, Shio Yen Tio, Maggie Chau, Ashvind Prabahran, Lynette Chee

Transpl Infect Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell.
Jacinta Perram, Duncan Purtill, Ashish Bajel, Jason Butler, Tracey O'Brien, Lynette Chee

Intern Med J· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-relapse cytopenias following allogeneic stem cell transplantation, a case based review.
Ashvind Prabahran, Rachel Koldej, Lynette Chee, Jeff Szer, David Ritchie

Bone Marrow Transplant· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial.
Abby Douglas, Karin Thursky, Timothy Spelman, Jeff Szer, Ashish Bajel, Lynette Chee

Lancet Haematol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The improvement in overall survival from unrelated donor transplantation in Australia and New Zealand is driven by a reduction in non-relapse mortality: A study from the ABMTRR.
David Kliman, Steven Tran, Glen Kennedy, Cameron Curley, Angela McLean, Lynette Chee

Bone Marrow Transplant· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement.
Anoop K Enjeti, Rishu Agarwal, Piers Blombery, Lynette Chee, Chong Chyn Chua

Pathology· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulation of immune cell and cytokine signalling correlates with clinical outcomes in myelodysplastic syndrome (MDS).
Lynette Chee, David Ritchie, Mandy Ludford-Menting, Jane Ripley, Jessica Chung

Eur J Haematol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features, pathophysiology, and therapy of poor graft function post-allogeneic stem cell transplantation.
Ashvind Prabahran, Rachel Koldej, Lynette Chee, David Ritchie

Blood Adv· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy.
Nina Orfali, Mei-Jie Zhang, Mariam Allbee-Johnson, Jaap Jan Boelens, Andrew S Artz, Lynette Chee

Transplant Cell Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults.
Lynette Chee

Transplant Cell Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021.
Anna Khanina, Shio Yen Tio, Michelle R Ananda-Rajah, Sarah E Kidd, Eloise Williams, Lynette Chee

Intern Med J· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis